Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Early emergence of anti-HCV antibody implicates donor origin in recipients of an HCV-infected organ.

Porrett PM, Reese PP, Holzmayer V, Coller KE, Kuhns M, Van Deerlin VM, Gentile C, Smith JR, Sicilia A, Woodards A, McLean R, Abt P, Bloom RD, Reddy KR, Blumberg E, Cloherty G, Goldberg D.

Am J Transplant. 2019 May 7. doi: 10.1111/ajt.15415. [Epub ahead of print]

PMID:
31066215
2.

Identification of a putative novel genotype 3/rabbit hepatitis E virus (HEV) recombinant.

Luk KC, Coller KE, Dawson GJ, Cloherty GA.

PLoS One. 2018 Sep 11;13(9):e0203618. doi: 10.1371/journal.pone.0203618. eCollection 2018.

3.

Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohort.

Rodgers MA, Holzmayer V, Vallari A, Olivo A, Forberg K, Fuhrman J, Coller KE, Awazi B, Kenmegne Sidje JB, Frankel MB, Berg MG, Mbanya D, Ndembi N, Cloherty GA.

J Viral Hepat. 2019 Jan;26(1):30-37. doi: 10.1111/jvh.12996. Epub 2018 Oct 3.

PMID:
30187640
4.

High prevalence of hepatitis delta virus in Cameroon.

Butler EK, Rodgers MA, Coller KE, Barnaby D, Krilich E, Olivo A, Cassidy M, Mbanya D, Kaptue L, Ndembi N, Cloherty G.

Sci Rep. 2018 Aug 2;8(1):11617. doi: 10.1038/s41598-018-30078-5.

5.

Performance Evaluation of a Prototype Architect Antibody Assay for Babesia microti.

Cheng K, Coller KE, Marohnic CC, Pfeiffer ZA, Fino JR, Elsing RR, Bergsma J, Marcinkus MA, Kar AK, Gumbs OH, Otis KS, Fishpaugh J, Schultz PW, Pope MR, Narvaez AR, Wong SJ, Madison-Antenucci S, Leary TP, Dawson GJ.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00460-18. doi: 10.1128/JCM.00460-18. Print 2018 Aug.

6.

Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.

Baktash Y, Madhav A, Coller KE, Randall G.

Cell Host Microbe. 2018 Mar 14;23(3):382-394.e5. doi: 10.1016/j.chom.2018.02.005.

7.

Development and performance of prototype serologic and molecular tests for hepatitis delta infection.

Coller KE, Butler EK, Luk KC, Rodgers MA, Cassidy M, Gersch J, McNamara AL, Kuhns MC, Dawson GJ, Kaptue L, Bremer B, Wedemeyer H, Cloherty GA.

Sci Rep. 2018 Feb 1;8(1):2095. doi: 10.1038/s41598-018-20455-5.

8.

Development of a high-throughput multiplexed real time RT-PCR assay for detection of human pegivirus 1 and 2.

Frankel M, Forberg K, Coller KE, Berg MG, Hackett J Jr, Cloherty G, Dawson GJ.

J Virol Methods. 2017 Mar;241:34-40. doi: 10.1016/j.jviromet.2016.12.013. Epub 2016 Dec 22.

PMID:
28012898
9.

Antibodies to the Novel Human Pegivirus 2 Are Associated with Active and Resolved Infections.

Coller KE, Berg MG, Frankel M, Forberg K, Surani R, Chiu CY, Hackett J Jr, Dawson GJ.

J Clin Microbiol. 2016 Aug;54(8):2023-30. doi: 10.1128/JCM.00515-16. Epub 2016 May 25.

10.
11.

Molecular determinants and dynamics of hepatitis C virus secretion.

Coller KE, Heaton NS, Berger KL, Cooper JD, Saunders JL, Randall G.

PLoS Pathog. 2012 Jan;8(1):e1002466. doi: 10.1371/journal.ppat.1002466. Epub 2012 Jan 5.

12.

RNA interference and single particle tracking analysis of hepatitis C virus endocytosis.

Coller KE, Berger KL, Heaton NS, Cooper JD, Yoon R, Randall G.

PLoS Pathog. 2009 Dec;5(12):e1000702. doi: 10.1371/journal.ppat.1000702. Epub 2009 Dec 24.

13.

The kinase activity of pseudorabies virus US3 is required for modulation of the actin cytoskeleton.

Van den Broeke C, Deruelle M, Nauwynck HJ, Coller KE, Smith GA, Van Doorsselaere J, Favoreel HW.

Virology. 2009 Mar 1;385(1):155-60. doi: 10.1016/j.virol.2008.11.050. Epub 2009 Jan 12.

14.

Two viral kinases are required for sustained long distance axon transport of a neuroinvasive herpesvirus.

Coller KE, Smith GA.

Traffic. 2008 Sep;9(9):1458-70. doi: 10.1111/j.1600-0854.2008.00782.x. Epub 2008 Jun 28.

15.

The capsid and tegument of the alphaherpesviruses are linked by an interaction between the UL25 and VP1/2 proteins.

Coller KE, Lee JI, Ueda A, Smith GA.

J Virol. 2007 Nov;81(21):11790-7. Epub 2007 Aug 22.

16.

The Herpesvirus capsid surface protein, VP26, and the majority of the tegument proteins are dispensable for capsid transport toward the nucleus.

Antinone SE, Shubeita GT, Coller KE, Lee JI, Haverlock-Moyns S, Gross SP, Smith GA.

J Virol. 2006 Jun;80(11):5494-8.

17.

Targeting of herpesvirus capsid transport in axons is coupled to association with specific sets of tegument proteins.

Luxton GW, Haverlock S, Coller KE, Antinone SE, Pincetic A, Smith GA.

Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5832-7. Epub 2005 Mar 28.

Supplemental Content

Loading ...
Support Center